The University of Warwick Library - WebBridge

Neo-tAnGo: a neoadjuvant randomized phase III trial of epirubicin/cyclophosphamide and paclitaxel +/- gemcitabine in the treatment of women with high-risk early breast cancer (EBC): first report of the primary endpoint, pathological complete response (pCR)
Earl, Helena M..  45th Annual Meeting of the American Society of Clinical Oncology.  v. Vol.27. no. No.15 Suppl. S.   2009-05-20. p. 60 - issn: 0732-183X .   

Online access not found

Sorry - based on the information provided, WebBridge cannot offer appropriate links.